Compliance Rate
Compliance Rate
40.0%
Compliant submissions
2
Incompliant submissions
3
Total trials
5
My Organizations' Clinical Trials
Showing 175 of 2418 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/20
End: 05/16/22
Due: 05/16/23
Phase: N/A
Priority: Normal
Start: 08/31/09
End: 08/31/10
Due: 08/31/11
Phase: N/A
Priority: Normal
Start: 04/01/18
End: 08/31/18
Due: 08/31/19
Phase: N/A
Priority: Normal
Start: 07/31/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/10/21
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 02/18/25
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 08/01/25
End: 07/01/28
Due: 07/01/29
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 08/01/24
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 01/09/23
End: 01/01/29
Due: 01/01/30
Phase: N/A
Priority: Normal
Start: 02/03/25
End: 07/01/27
Due: 07/01/28
Phase: N/A
Priority: Normal
Start: 05/31/00
End: 04/30/07
Due: 04/30/08
Phase: N/A
Priority: Normal
Start: 01/05/21
End: 08/30/21
Due: 08/30/22
Phase: N/A
Priority: Normal
Start: 07/25/07
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 03/01/22
End: 06/01/26
Due: 06/01/27
Phase: N/A
Priority: Normal
Start: 05/31/04
End: 12/31/09
Due: 12/31/10
Phase: N/A
Priority: Normal
Start: 06/21/16
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 07/01/26
End: 12/31/28
Due: 12/31/29
Electronic Pill Bottle Monitoring to Promote Medication Adherence for People With Multiple Sclerosis
Phase: N/A
Priority: Normal
Start: 11/15/19
End: 01/26/21
Due: 01/26/22
Double-blind Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 06/30/15
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 03/13/20
End: 04/08/20
Due: 04/08/21
Phase: N/A
Priority: Normal
Start: 10/13/22
End: 06/01/25
Due: 06/01/26
Phase: N/A
Priority: Normal
Start: 10/18/23
End: 04/11/24
Due: 04/11/25